Bessemer Group
WVE icon

Bessemer Group’s Wave Life Sciences WVE Stock Holding History

Bessemer Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41K Sell
7,120
-2,805
-28% -$18.6K ﹤0.01% 1763
2026
Q1 		$72K Sell
9,925
-37
-0.4% -$482 ﹤0.01% 1582
2025
Q4 		$170K Buy
9,962
+37
+0.4% +$376 ﹤0.01% 1382
2025
Q3 		$72K Buy
9,925
+9,135
+1,156% +$73.9K ﹤0.01% 1343
2025
Q2 		$5K Buy
+790
New +$5.22K ﹤0.01% 2049
2020
Q3 		– Sell
-78,400
Closed -$816K – 1693
2020
Q2 		$816K Buy
+78,400
New +$738K ﹤0.01% 861

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Bessemer Group's WVE Position: Q2 2026 in Review

Bessemer Group reduced its Wave Life Sciences (WVE) stake by 28% in Q2 2026, selling an estimated $18.6K and leaving 7,120 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

Bessemer Group first reported a position in WVE in Q2 2020 and has held it in 6 quarters since. The position peaked at $816K in Q2 2020. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Bessemer Group held 7,120 shares of Wave Life Sciences worth $41K as of Q2 2026.
  • Bessemer Group sold 2,805 Wave Life Sciences shares in Q2 2026, an estimated $18.6K.
  • Wave Life Sciences made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1763 holding.
  • Bessemer Group first reported a position in Wave Life Sciences in Q2 2020 and has held it in 6 quarters since.
  • Bessemer Group's Wave Life Sciences position peaked at $816K in Q2 2020.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.